Four-Pronged attack on deadly brain cancer shows promise
NCT ID NCT03532295
Summary
This study tested a combination of four treatments for patients whose aggressive brain cancer (glioblastoma) had returned. The goal was to see if using two immunotherapy drugs alongside radiation and a targeted therapy could help the immune system fight the cancer better, shrink tumors, and help patients live longer. It involved 51 adults whose cancer had recurred and who were eligible for more radiation treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic
Phoenix, Arizona, 85259, United States
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
-
Wake Forest Baptist Medical Center
Winston-Salem, North Carolina, 27157, United States
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.